The TH1902 Docetaxel Peptide-Drug Conjugate Inhibits Xenografts Growth of Human SORT1-Positive Ovarian and Triple-Negative Breast Cancer Stem-like Cells
<b>Background:</b> Breast and ovarian cancer stem cells (CSC) can contribute to the invasive and chemoresistance phenotype of tumors. TH1902, a newly developed sortilin (SORT1)-targeted peptide-docetaxel conjugate is currently in phase-1 clinical trial. Whether TH1902 impacts the chemore...
Saved in:
Main Authors: | Michel Demeule (Author), Cyndia Charfi (Author), Jean-Christophe Currie (Author), Alain Zgheib (Author), Bogdan Alexandru Danalache (Author), Richard Béliveau (Author), Christian Marsolais (Author), Borhane Annabi (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
by: Borhane Annabi, et al.
Published: (2012) -
Resveratrol Targeting of Carcinogen-Induced Brain Endothelial Cell Inflammation Biomarkers MMP-9 and COX-2 is Sirt1-Independent
by: Borhane Annabi, et al.
Published: (2012) -
Resveratrol Targeting of Carcinogen-Induced Brain Endothelial Cell Inflammation Biomarkers MMP-9 and COX-2 is Sirt1-Independent
by: Borhane Annabi, et al.
Published: (2012) -
Low intracellular ATP levels exacerbate carcinogen-induced inflammatory stress response and inhibit in vitro tubulogenesis in human brain endothelial cells
by: Elizabeth Tahanian, et al.
Published: (2011) -
Identification of two cancer stem cell-like populations in triple-negative breast cancer xenografts
by: Jun Nakayama, et al.
Published: (2022)